Here, we evaluated whether development of drug resistance upregulates EDB-FN expression in the CRC cells, using qRT-PCR and EDB-FN-specific peptide probe ZD2-Cy5.5 52 in 2D and 3D cultures, respectively. Here, FN1 is linked to colorectal carcinoma.